卫宁健康
(300253)
| 流通市值：153.17亿 | | | 总市值：186.23亿 |
| 流通股本：18.11亿 | | | 总股本：22.01亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 397,456,279.95 | 2,106,166,908.59 | 1,295,802,097.22 | 839,150,865.03 |
| 营业收入 | 397,456,279.95 | 2,106,166,908.59 | 1,295,802,097.22 | 839,150,865.03 |
| 二、营业总成本 | 464,227,086.2 | 2,323,174,988.34 | 1,538,894,486.85 | 896,266,883.34 |
| 营业成本 | 275,146,136.39 | 1,414,739,619.03 | 919,056,862.86 | 533,614,486.13 |
| 税金及附加 | 3,027,847.08 | 14,945,739.37 | 10,156,317.76 | 7,610,570.15 |
| 销售费用 | 51,356,578.05 | 319,760,538.72 | 205,661,234.39 | 121,522,606.37 |
| 管理费用 | 38,698,318.24 | 178,034,643.6 | 118,512,491.76 | 80,174,353.77 |
| 研发费用 | 80,501,214.58 | 333,543,196.22 | 240,826,375.62 | 124,047,618.47 |
| 财务费用 | 15,496,991.86 | 62,151,251.4 | 44,681,204.46 | 29,297,248.45 |
| 其中:利息费用 | 17,707,561.39 | 68,600,185.44 | 50,376,737.81 | 33,271,828 |
| 其中:利息收入 | 2,322,202.51 | 6,920,521.86 | 6,018,543.2 | 4,179,154.49 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -922,774.07 | -24,406,986.94 | -15,191,089.5 | -13,185,501.88 |
| 加:投资收益 | -7,136,990.91 | -26,099,660.2 | -19,085,260.63 | -9,500,369.91 |
| 资产处置收益 | 2,332.33 | 3,050,417.08 | 2,173,746.3 | 2,370,375.38 |
| 资产减值损失(新) | -3,726,883.3 | -140,857,646.94 | -61,617,061.11 | -86,867,652.57 |
| 信用减值损失(新) | 35,891,106.02 | -110,650,502.69 | -5,727,617.59 | 3,821,899.61 |
| 其他收益 | 29,312,009.63 | 97,832,804.8 | 79,559,235.85 | 54,589,550.6 |
| 四、营业利润 | -13,352,006.55 | -418,139,654.64 | -262,980,436.31 | -105,887,717.08 |
| 加:营业外收入 | 10,165.22 | 222,783.54 | 64,444.61 | 617.94 |
| 减:营业外支出 | 94,123.04 | 24,559,841.67 | 58,032,393.37 | 57,653,427.44 |
| 五、利润总额 | -13,435,964.37 | -442,476,712.77 | -320,948,385.07 | -163,540,526.58 |
| 减:所得税费用 | -12,096,032.52 | -58,304,238.43 | -73,188,278.12 | -40,721,110.14 |
| 六、净利润 | -1,339,931.85 | -384,172,474.34 | -247,760,106.95 | -122,819,416.44 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -1,339,931.85 | -384,172,474.34 | -247,760,106.95 | -122,819,416.44 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 14,030,859.04 | -373,882,252.65 | -241,386,078.27 | -117,969,780.09 |
| 少数股东损益 | -15,370,790.89 | -10,290,221.69 | -6,374,028.68 | -4,849,636.35 |
| 扣除非经常损益后的净利润 | 1,526,701.35 | -354,567,960.77 | -227,518,349.84 | -99,821,597.82 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.01 | -0.17 | -0.11 | -0.05 |
| (二)稀释每股收益 | 0.01 | -0.17 | -0.11 | -0.05 |
| 九、综合收益总额 | -1,339,931.85 | -384,172,474.34 | -247,760,106.95 | -122,819,416.44 |
| 归属于母公司股东的综合收益总额 | 14,030,859.04 | -373,882,252.65 | -241,386,078.27 | -117,969,780.09 |
| 归属于少数股东的综合收益总额 | -15,370,790.89 | -10,290,221.69 | -6,374,028.68 | -4,849,636.35 |
| 公告日期 | 2026-04-23 | 2026-04-15 | 2025-10-28 | 2025-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |